Caribou Biosciences, Inc.

NasdaqGS:CRBU 株式レポート

時価総額：US$169.0m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Caribou Biosciences マネジメント

マネジメント 基準チェック /24

現在、CEO に関する十分な情報がありません。

主要情報

Rachel Haurwitz

最高経営責任者

US$3.1m

報酬総額

CEO給与比率20.0%
CEO在任期間13yrs
CEOの所有権0.04%
経営陣の平均在職期間2.9yrs
取締役会の平均在任期間3.4yrs

経営陣の近況

Recent updates

Caribou Biosciences: CB-010, chRDNA Technology Continue To Show Promise In Gene Editing

Sep 30

Here's Why We're Watching Caribou Biosciences' (NASDAQ:CRBU) Cash Burn Situation

Sep 06
Here's Why We're Watching Caribou Biosciences' (NASDAQ:CRBU) Cash Burn Situation

Caribou Biosciences, Inc.'s (NASDAQ:CRBU) Share Price Boosted 39% But Its Business Prospects Need A Lift Too

Jul 26
Caribou Biosciences, Inc.'s (NASDAQ:CRBU) Share Price Boosted 39% But Its Business Prospects Need A Lift Too

Caribou Biosciences: Promising Gene Editing Therapies With Strong Buy Potential

Jul 03

Little Excitement Around Caribou Biosciences, Inc.'s (NASDAQ:CRBU) Revenues As Shares Take 43% Pounding

Jun 05
Little Excitement Around Caribou Biosciences, Inc.'s (NASDAQ:CRBU) Revenues As Shares Take 43% Pounding

Caribou Biosciences: 2 Clinical Data Updates In 2024 Could Bring Value

Apr 18

More Unpleasant Surprises Could Be In Store For Caribou Biosciences, Inc.'s (NASDAQ:CRBU) Shares After Tumbling 25%

Apr 17
More Unpleasant Surprises Could Be In Store For Caribou Biosciences, Inc.'s (NASDAQ:CRBU) Shares After Tumbling 25%

Caribou Biosciences, Inc.'s (NASDAQ:CRBU) 25% Share Price Surge Not Quite Adding Up

Feb 15
Caribou Biosciences, Inc.'s (NASDAQ:CRBU) 25% Share Price Surge Not Quite Adding Up

Caribou Biosciences: Under The Radar With Catalysts Approaching

Feb 01

Caribou Biosciences (NASDAQ:CRBU) Is In A Good Position To Deliver On Growth Plans

Jan 10
Caribou Biosciences (NASDAQ:CRBU) Is In A Good Position To Deliver On Growth Plans

Caribou Biosciences, Inc.'s (NASDAQ:CRBU) 28% Price Boost Is Out Of Tune With Revenues

Nov 18
Caribou Biosciences, Inc.'s (NASDAQ:CRBU) 28% Price Boost Is Out Of Tune With Revenues

Companies Like Caribou Biosciences (NASDAQ:CRBU) Are In A Position To Invest In Growth

Feb 24
Companies Like Caribou Biosciences (NASDAQ:CRBU) Are In A Position To Invest In Growth

Caribou Biosciences: Strong Momentum Possible If Higher Dose Shows Durability

Oct 12

Companies Like Caribou Biosciences (NASDAQ:CRBU) Are In A Position To Invest In Growth

Sep 16
Companies Like Caribou Biosciences (NASDAQ:CRBU) Are In A Position To Invest In Growth

Caribou Biosciences: Potential To Change CAR-T Landscape

Aug 01

Crispred CAR-T Cells In The Clinic

May 19

Caribou Biosciences, Inc. (NASDAQ:CRBU) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

May 13
Caribou Biosciences, Inc. (NASDAQ:CRBU) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Caribou Biosciences: Selling Close To Cash Balance

Apr 26

We're Not Very Worried About Caribou Biosciences' (NASDAQ:CRBU) Cash Burn Rate

Oct 26
We're Not Very Worried About Caribou Biosciences' (NASDAQ:CRBU) Cash Burn Rate

Caribou Biosciences: Another Gene Editor Hurt By The Allogene Hold

Oct 12

CEO報酬分析

Caribou Biosciences の収益と比較して、Rachel Haurwitz の報酬はどのように変化したか？
日付総報酬給与会社業績
Jun 30 2024n/an/a

-US$123m

Mar 31 2024n/an/a

-US$115m

Dec 31 2023US$3mUS$623k

-US$102m

Sep 30 2023n/an/a

-US$95m

Jun 30 2023n/an/a

-US$111m

Mar 31 2023n/an/a

-US$108m

Dec 31 2022US$833kUS$513k

-US$99m

Sep 30 2022n/an/a

-US$91m

Jun 30 2022n/an/a

-US$85m

Mar 31 2022n/an/a

-US$73m

Dec 31 2021US$6mUS$527k

-US$67m

Sep 30 2021n/an/a

-US$63m

Jun 30 2021n/an/a

-US$50m

Mar 31 2021n/an/a

-US$38m

Dec 31 2020US$664kUS$450k

-US$34m

Dec 31 2019US$540kUS$425k

-US$23m

報酬と市場: Rachelの 総報酬 ($USD 3.12M ) は、 US市場 ($USD 1.58M ) の同規模の企業の平均を上回っています。

報酬と収益: Rachelの報酬は増加しましたが、会社は利益を上げていません。

CEO（最高経営責任者

Rachel Haurwitz (38 yo)

13yrs

在職期間

US$3,116,547

報酬

Dr. Rachel E. Haurwitz, Ph D., has been the President and Chief Executive Officer at Caribou Biosciences, Inc. since October 2011. She served as independent Director at Seer, Inc. since December 21, 2023 u...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Rachel Haurwitz
Co-Founder13yrsUS$3.12m0.044%
$ 74.8k
Steven Kanner
Chief Scientific Officer7.3yrsUS$1.22m0.39%
$ 662.1k
Barbara McClung
Chief Legal Officer & Corporate Secretary9.5yrsUS$1.22m0.42%
$ 704.2k
Daniel Poon
Vice President of Operations & Information Technology2.3yrsデータなしデータなし
Ryan Fischesser
Principal Accounting Officerless than a yearデータなしデータなし
Timothy Kelly
Chief Technology Officerless than a yearデータなしデータなし
Amy Figueroa
Vice President of Investor Relations & Corporate Communications2.9yrsデータなしデータなし
Reigin Zawadzki
Chief People Officer1.1yrsデータなしデータなし
Ruhi Khan
Chief Business Officer2.9yrsUS$1.04m0%
$ 0

2.9yrs

平均在職期間

55yo

平均年齢

経験豊富な経営陣: CRBUの経営陣は 経験豊富 であると考えられます ( 2.6年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Rachel Haurwitz
Co-Founder13yrsUS$3.12m0.044%
$ 74.8k
Andrew Guggenhime
Independent Chairman3.5yrsUS$202.74k0%
$ 0
Jennifer Doudna
Member of Scientific Advisory Boardno dataデータなしデータなし
Scott Braunstein
Independent Director3.3yrsUS$155.86k0%
$ 0
Katy Rezvani
Member of Scientific Advisory Boardno dataデータなしデータなし
Martin Jinek
Member of Scientific Advisory Boardno dataデータなしデータなし
Natalie Sacks
Independent Director6.4yrsUS$136.99k0%
$ 0
Cameron Turtle
Member of Scientific Advisory Boardno dataデータなしデータなし
Ran Zheng
Independent Director3.1yrsUS$157.20k0%
$ 0
Nancy Whiting
Independent Director3.2yrsUS$140.62k0%
$ 0
Noopur Raje
Member of Scientific Advisory Boardno dataデータなしデータなし
Ami Bhatt
Member of Scientific Advisory Boardno dataデータなしデータなし

3.4yrs

平均在職期間

59yo

平均年齢

経験豊富なボード: CRBUの 取締役会 は 経験豊富 であると考えられます ( 3.1年の平均在任期間)。